Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(17):1344; doi:10.1093/jnci/djg054
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Rookus, M. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rookus, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Potential for Bias in Studies on Efficacy of Prophylactic Surgery for BRCA1 and BRCA2 Mutation Carriers

Matti A. Rookus

Correspondence to: Matti A. Rookus, PhD, Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands (e-mail: m.rookus@nki.nl).

The first 10% of the full text of this article appears below.

Dr. Foulkes indicates correctly that the effect of parity on breast and ovarian cancer risk among BRCA1 and BRCA2 mutation carriers may be different from that in the general population. However, whether this difference really exists remains to be . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?